MY148457A - Combination preparations comprising slv308 and a dopamine agonist - Google Patents
Combination preparations comprising slv308 and a dopamine agonistInfo
- Publication number
- MY148457A MY148457A MYPI20085078A MYPI20085078A MY148457A MY 148457 A MY148457 A MY 148457A MY PI20085078 A MYPI20085078 A MY PI20085078A MY PI20085078 A MYPI20085078 A MY PI20085078A MY 148457 A MY148457 A MY 148457A
- Authority
- MY
- Malaysia
- Prior art keywords
- slv308
- dopamine agonist
- combination preparations
- acceptable salt
- pharmacologically acceptable
- Prior art date
Links
- 239000003136 dopamine receptor stimulating agent Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- YVPUUUDAZYFFQT-UHFFFAOYSA-N 7-(4-methylpiperazin-1-yl)-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C1=CC=CC2=C1OC(=O)N2 YVPUUUDAZYFFQT-UHFFFAOYSA-N 0.000 abstract 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000005793 Restless legs syndrome Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000010249 dopaminergic function Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81405106P | 2006-06-16 | 2006-06-16 | |
| EP06115583 | 2006-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY148457A true MY148457A (en) | 2013-04-30 |
Family
ID=38434785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20085078A MY148457A (en) | 2006-06-16 | 2007-06-15 | Combination preparations comprising slv308 and a dopamine agonist |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2035002A1 (ko) |
| JP (1) | JP2009539941A (ko) |
| KR (1) | KR20090031908A (ko) |
| AU (1) | AU2007259255A1 (ko) |
| CA (1) | CA2654719A1 (ko) |
| EA (1) | EA015073B1 (ko) |
| IL (1) | IL195532A0 (ko) |
| MY (1) | MY148457A (ko) |
| NO (1) | NO20090164L (ko) |
| WO (1) | WO2007144421A1 (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0027020D0 (en) | 2000-11-03 | 2000-12-20 | Univ Manchester | Treatment of movement disorders |
| US20090247537A1 (en) * | 2008-03-25 | 2009-10-01 | William Dale Overfield | Methods for preventing or treating bruxism using dopaminergic agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7596407B2 (en) * | 2004-03-26 | 2009-09-29 | Solvay Pharmaceuticals, B.V. | Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds |
| JP5081622B2 (ja) * | 2004-09-21 | 2012-11-28 | 山▲東緑▼叶制▲薬▼有限公司 | ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法 |
| ES2318783T3 (es) * | 2005-08-22 | 2009-05-01 | Solvay Pharmaceuticals B.V. | N-oxidos como profarmacos de derivados de piperazina y piperadina. |
-
2007
- 2007-06-15 CA CA002654719A patent/CA2654719A1/en not_active Abandoned
- 2007-06-15 EP EP07730193A patent/EP2035002A1/en not_active Withdrawn
- 2007-06-15 AU AU2007259255A patent/AU2007259255A1/en not_active Abandoned
- 2007-06-15 WO PCT/EP2007/055955 patent/WO2007144421A1/en active Search and Examination
- 2007-06-15 EA EA200970021A patent/EA015073B1/ru not_active IP Right Cessation
- 2007-06-15 KR KR1020097001024A patent/KR20090031908A/ko not_active Application Discontinuation
- 2007-06-15 JP JP2009514809A patent/JP2009539941A/ja active Pending
- 2007-06-15 MY MYPI20085078A patent/MY148457A/en unknown
-
2008
- 2008-11-26 IL IL195532A patent/IL195532A0/en unknown
-
2009
- 2009-01-12 NO NO20090164A patent/NO20090164L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009539941A (ja) | 2009-11-19 |
| IL195532A0 (en) | 2009-09-01 |
| KR20090031908A (ko) | 2009-03-30 |
| EP2035002A1 (en) | 2009-03-18 |
| NO20090164L (no) | 2009-01-14 |
| CA2654719A1 (en) | 2007-12-21 |
| AU2007259255A1 (en) | 2007-12-21 |
| EA015073B1 (ru) | 2011-04-29 |
| WO2007144421A1 (en) | 2007-12-21 |
| EA200970021A1 (ru) | 2009-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU93321I2 (fr) | Ibrutinib, ou un sel pharmaceutiquement acceptable de celui-ci | |
| MX2020012868A (es) | Metodos y composiciones para trastornos del sue?o y otros trastornos. | |
| TWI320316B (en) | Methods for inhibiting hscd activity,pyridazine derivatives and use and pharmaceutical composition thereof | |
| IL186200A (en) | Use of amylin and agonists, analogues and derivatives of amylin for the preparation of a drug for the treatment of psychiatric illness | |
| MX2009011359A (es) | Derivados de pirimidinona y sus metodos de uso. | |
| HK1100765A1 (en) | Use of rotigotine for treating and preventing parkinson's plus syndrome | |
| MX2009011358A (es) | Derivados de pirimidinona y metodos para su uso. | |
| PL2026803T3 (pl) | Kompozycje R(+) i S(-) pramipeksolu i sposoby ich zastosowania | |
| WO2009091576A3 (en) | Parenteral formulations of dopamine agonists | |
| MX2010004450A (es) | Derivados heterociclo biciclicos y su uso como moduladores de la actividad de gpr119. | |
| SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
| UA97795C2 (uk) | Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки | |
| MX2009000900A (es) | Derivados de imidazolonas sustituidas, preparacion y usos. | |
| IL196113A0 (en) | N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof | |
| MY149854A (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
| MX2010006204A (es) | Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| ME01192B (me) | Metod pripreme i upotreba farmakološki aktivnog n-karbamoilmetil-4(r)-fenil-2-pirolidinona | |
| TW200801022A (en) | Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments | |
| WO2004069146A3 (en) | L-dopa amide derivatives and uses thereof | |
| WO2009068708A8 (es) | Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo | |
| EA202091356A1 (ru) | A2a АНТАГОНИСТЫ КАК УСИЛИТЕЛИ КОГНИТИВНОЙ И МОТОРНОЙ ФУНКЦИЙ | |
| CL2007001517A1 (es) | Compuestos derivados de carboxamida; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, en terapia de trastornos gastrointestinales funcionales, sindrome del intestino irritable, cancer, parkinson, alzheimer, desordenes cardiovasculares. | |
| IL185300A0 (en) | New pharmaceutical compositions useful in the treatment of parkinson's disease | |
| WO2007144422A3 (en) | Combination preparations comprising bifeprunox and l-dopa |